StemCells Therapy

(SACRAMENTO, Calif.) – Experts from UC Davis Health System will share the latest research about regenerative medicine, with a focus on chronic pain and the promise of stem cell therapies, during a community forum on the university's Sacramento campus. The discussion takes place on Tuesday, Feb. 7, from 6- 7:30 p.m.

WALTHAM, Mass.–(BUSINESS WIRE)– Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity Musculoskeletal Conference on February 7th at 3:30pm PT at the Parc 55 Wyndham in San Francisco. Mr.

EXTON, Pa., Feb. 2, 2012 /PRNewswire/ — Kensey Nash Corporation (NASDAQ: KNSY – News), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported …

18-11-2011 14:04 Rehabilitation Medicine Update, New “Regenerative Medical Rehabilitation” Management Procedure.The Prospective Role Of The Trans Cranial Magnetic Stimulation TCMS (TMS) Technique In Brain Regeneration And Re-education. According To The USA — FDA In 2009 : Transcranial Magnetic Stimulation Is A Procedure That Uses Magnetic Fields To Stimulate Nerve Cells In The Brain To Improve Symptoms Of Depression.

13-12-2011 14:45 Alan Trounson, PhD and President of the California Institute for Regenerative Medicine, offered a positive and forward looking keynote address. Trounson provided an update on CIRM’s translational roadmap to regenerative medicine and outlined their accomplishments with over $300 million in funding for human embryonic stem cell research, adult stem cells, cancer stem cells, reprogrammed stem cells and endogenous stem cells for multiple treatments.

Speakers include Advanced Cell Technology, Athersys, Cytori, Dendreon, Genzyme-Sanofi, Johnson & Johnson, Mesoblast and Shire WASHINGTON, DC, January 5, 2012 – The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine (RM) community, today released the agenda for its second annual State of the Industry Briefing and RM Insight Track.

19-10-2011 18:19 Mark Walter, MD is an internationally recognized expert in the field of Regenerative Medicine. He is McGill trained (1980) and has specialized in Sports Medicine and healing sports-related injuries for over three decades.

Halfway through its initial ten-year mandate, the California Institute for Regenerative Medicine (CIRM) in San Francisco is confronting a topic familiar to anyone at middle age: its own mortality.

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the Aberdeen Royal Infirmary, the largest of the Grampian University Hospitals in Scotland, has been confirmed as a site for its Phase 1/2 human clinical trial for Stargardt’s Macular Dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .

Regenerative medicine company Juventas Therapeutics [1] is touting the results from 12-month data of a phase 1 clinical trial of heart failure patients.

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today the dosing of an additional patient in its Phase 1/2 trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .

30-11-2011 05:21 Kevin Shakesheff, University of Nottingham. Regenerative medicine: Opportunities to transform therapies

Advanced Cell Technology, Inc.

Regenerative medicine company KeraNetics, whose biomaterials research into healing damaged tissue is already in the U.S. military’s sights, is now raising a targeted $7 million in equity financing. The Winston-Salem, North Carolina company has raised $4.7 million from 26 investors so far in a securities sale that began on Dec

TAP Biosystems in Cambridge is collaborating with a major regenerative medicine company to develop a custom manufacturing system to ensure the consistent quality of the customer’s innovative cell-based therapy. Read more…

17-01-2012 15:42 Are you tired of fad diets that promise results without delivering? Then it’s time to visit the Center for Preventative and Regenerative Medicine, where patients are our number one priority

A study exploring lung repair and tissue regeneration to fight lung diseases by a team at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia has received a $2.5 million grant. The grant was awarded by the National Heart, Lung, and Blood Institute’s Lung Repair and Regeneration Consortium to six institutions, including Penn,

AUSTIN, Texas , Jan. 17, 2012 /PRNewswire/ –  SpineSmith , a Celling Biosciences company that designs, develops and markets innovative technologies in the field of regenerative medicine, is pleased to …

AxoGen, Inc. , an emerging regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported the publication of peer-reviewed clinical research conducted at twelve leading US surgical sites and led by the Buncke Clinic in San Francisco.

09-01-2012 16:22